For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Nereus Pharmaceuticals, Inc.

USPTO Granted Patents = 36

CIPO Patents = 3

EPO Patents = 6

Forward Citations = 543

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Michael A Palladino (16 out of 24 patents)

Barbara Christine Potts (11 out of 12 patents)

Yoshio Hayashi (8 out of 10 patents)

4. Kin S Lam (7 out of 32 patents)

5. Emmanuel A Theodorakis (6 out of 16 patents)

6. Venkata Rami Reddy Macherla (6 out of 7 patents)

7. Ta-Hsiang Chao (6 out of 7 patents)

8. Jennifer Grodberg (6 out of 6 patents)

9. Benjamin Nicholson (6 out of 7 patents)

10. Rama Manam (5 out of 13 patents)

11. Katherine A McArthur (5 out of 6 patents)

12. Venkat Rami Reddy Macherla (4 out of 8 patents)

13. Saskia Theodora Cornelia Neuteboom (4 out of 5 patents)

14. Taotao Ling (4 out of 4 patents)

15. Scott Sherman Mitchell (4 out of 4 patents)

36 patents: Sort by Forward Citations

1. 8314251 - Total synthesis of salinosporamide A and analogs thereof (2012-11-20),

2. 8247552 - Analogs of dehydrophenylahistins and their therapeutic use (2012-08-21),

3. 8227503 - Proteasome inhibitors (2012-07-24),

4. 8168803 - Methods of using [3.2.0] heterocyclic compounds and analogs thereof (2012-05-01),

5. 8133915 - Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators (2012-03-13),

6. 8067616 - Total synthesis of salinosporamide A and analogs thereof (2011-11-29),

7. 8003802 - Total synthesis of Salinosporamide A and analogs thereof (2011-08-23),

8. 7956058 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof (2011-06-07),

9. 7935704 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof (2011-05-03),

10. 7919497 - Analogs of dehydrophenylahistins and their therapeutic use (2011-04-05),

11. 7910616 - Proteasome inhibitors (2011-03-22),

12. 7893299 - Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators (2011-02-22),

13. 7879892 - Anti-cancer and anti-microbial oxazolidinones (2011-02-01),

14. 7842814 - Total synthesis of salinosporamide A and analogs thereof (2010-11-30),

15. 7824698 - Lyophilized formulations of Salinosporamide A (2010-11-02),

Nereus Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for the treatment of cancer and other diseases. With a specialized expertise in natural product chemistry, Nereus utilizes a proprietary drug discovery platform to identify novel compounds with the potential to become breakthrough medicines. Through relentless exploration and cutting-edge research, Nereus is committed to advancing its pipeline of promising drug candidates and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

36 Patents

#161 in San Diego, CA

#2,179 in California

#9,190 in US

#18,176 in the World

San Diego, CA, United States of America

Nereus Pharmaceuticals, Inc.

Forward Citations = 543

44 inventors:

Michael A Palladino (16 out of 24 patents)

Barbara Christine Potts (11 out of 12 patents)

Yoshio Hayashi (8 out of 10 patents)

4. Kin S Lam (7 out of 32 patents)

5. Emmanuel A Theodorakis (6 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…